Atara Biotherapeutics (ATRA) Profit After Tax (2013 - 2026)
Atara Biotherapeutics (ATRA) posted Profit After Tax of -$4.1 million for Q1 2026, down 21.94% on a QoQ basis from -$3.4 million in Q4 2025, and down 110.91% year-over-year from $38.0 million in Q1 2025.
Atara Biotherapeutics (ATRA) Profit After Tax (2013 - 2026) Analysis & Trends
Atara Biotherapeutics' Profit After Tax history runs 14 years deep, the most recent figure standing at -$4.1 million for Q1 2026.
- Quarterly Profit After Tax fell 110.91% year-over-year to -$4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.5 million (up 40.27% YoY) and the FY2025 annual result came in at $32.7 million, up 138.28% from the prior year.
- Profit After Tax was -$4.1 million for Q1 2026 at Atara Biotherapeutics, down from -$3.4 million in the prior quarter.
- Across five years, Profit After Tax topped out at $38.0 million in Q1 2025 and bottomed at -$88.1 million in Q1 2022.
- A 5-year average of -$33.0 million and a median of -$21.9 million in 2024 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2023 — Profit After Tax slumped 485.08% — and 2025, when it surged 219.68%.
- Atara Biotherapeutics' Profit After Tax stood at -$74.6 million in 2022, then rose by 19.43% to -$60.1 million in 2023, then soared by 78.5% to -$12.9 million in 2024, then jumped by 73.68% to -$3.4 million in 2025, then retreated by 21.94% to -$4.1 million in 2026.
- Business Quant data shows ATRA's Profit After Tax at -$4.1 million in Q1 2026, -$3.4 million in Q4 2025, and -$4.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -453.82 Mn |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | -4.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.15 Mn |
| Dec 31, 2025 | -3.40 Mn |
| Sep 30, 2025 | -4.30 Mn |
| Jun 30, 2025 | 2.39 Mn |
| Mar 31, 2025 | 38.00 Mn |
| Dec 31, 2024 | -12.92 Mn |
| Sep 30, 2024 | -21.87 Mn |
| Jun 30, 2024 | -19.05 Mn |
| Mar 31, 2024 | -31.75 Mn |
| Dec 31, 2023 | -60.08 Mn |
| Sep 30, 2023 | -69.80 Mn |
| Jun 30, 2023 | -71.11 Mn |
| Mar 31, 2023 | -74.77 Mn |
| Dec 31, 2022 | -74.57 Mn |
| Sep 30, 2022 | -84.43 Mn |
| Jun 30, 2022 | 18.47 Mn |
| Mar 31, 2022 | -88.11 Mn |
| Dec 31, 2021 | -93.35 Mn |
| Sep 30, 2021 | -84.66 Mn |
| Jun 30, 2021 | -83.79 Mn |